Filtered By:
Vaccination: Influenza Vaccine
Countries: Iran Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 24 results found since Jan 2013.
Phylogenetic analysis and docking study of neuraminidase gene of influenza A/H1N1 viruses circulating in Iran from 2010 to 2019
This study highlighted the evolutionary trend of influenza A virus/H1N1 circulating in Iran, which provides a preliminary viewpoint for a better comprehension of new emerging strains' virulence and thus, more appropriate monitoring of influenza virus A/H1N1 during each outbreak season.PMID:37490957 | DOI:10.1016/j.virusres.2023.199182
Source: Virus Research - July 25, 2023 Category: Virology Authors: Sina Moeini Atefeh Mohebbi Behrokh Farahmand Parvaneh Mehrbod Fatemeh Fotouhi Source Type: research
Influenza Vaccine Booster Stimulates Antibody Response in Beta Thalassemia Major Patients
Lab Med. 2022 Jul 18:lmac035. doi: 10.1093/labmed/lmac035. Online ahead of print.ABSTRACTThe aim of this study was to evaluate antibody response against influenza vaccine in beta thalassemia major patients from Iran. Thirty beta thalassemia major patients were enrolled and divided into three groups: single dose (group 1), double dose (group 2), and control (group 3). Seroconversion, seroprotection, and geometric mean titer (GMT) assays were performed through hemagglutination inhibition (HI) on days 0, 14, and 60. Based on the results, the level of antibody titer was increased in group 2. Two weeks after vaccination, seroco...
Source: Cancer Control - July 18, 2022 Category: Cancer & Oncology Authors: Maryam Sheikh Abbas Ahmadi-Vasmehjani Mohammad Reza Atashzar Mohammad Hadi Karbalaie Niya Arefeh Ebrahimian Rasoul Baharlou Source Type: research
Modulation of Immune Responses Against HA1 Influenza Vaccine Candidate by B-lymphocyte Stimulator Cytokine in Mice
Iran J Allergy Asthma Immunol. 2022 Apr 11;21(2):207-214. doi: 10.18502/ijaai.v21i2.9228.ABSTRACTUtilizing subunit vaccines is one of the strategies to address influenza infection. Recent innovations have focused on high doses of vaccine antigens and immune enhancers or adjuvant to induce more robust and long-lasting immune responses. Here, an effect of the B cell-activating factor receptor (BAFF-R) to increase the magnitude and durability of immune responses of the recombinant HA1 (rHA1) protein against the H1N1 influenza virus was studied. The HA1 protein and the effector domain of BAFF-R were expressed in the pET-28a (+...
Source: Iranian Journal of Allergy, Asthma and Immunology - May 1, 2022 Category: Allergy & Immunology Authors: Seyedeh Mahsa Bagheri Yazdi Shahla Shahsavandi Fatemeh Fotouhi Majid Tebianian Mohammad Majid Ebrahimi Source Type: research
Recombinant hemagglutinin of swine H1N1 influenza virus expression in the insect cells: Formulation in Montanide ISA71 adjuvant and the potency studies
CONCLUSION: To summarize, the results showed that the recombinant protein with the MontanideTM ISA- 71 adjuvant developed a more appropriate level of immunity than Alum adjuvant, so it might be used as a safe and reliable vaccine against H1N1 virus for further research.PMID:35317113 | PMC:PMC8917850 | DOI:10.22038/IJBMS.2021.57053.12716
Source: Cancer Control - March 23, 2022 Category: Cancer & Oncology Authors: Sara Zahmati Morteza Taghizadeh Setareh Haghighat Reza Jalalirad Mehdi Mahdavi Source Type: research
Immunogenicity and Safety of Three WHO Prequalified (DTwP -HB-Hib) Pentavalent Combination Vaccines Administered As Per Iranian National Immunization Plan in Iranian Infants: A Randomized, Phase III Study
CONCLUSIONS: Pentavac and Shan 5 had similar immunogenicity, the former having better immunogenicity against pertussis than Pentabio. Pentavac and Pentabio had a comparable safety profile.PMID:34939580
Source: Indian Pediatrics - December 23, 2021 Category: Pediatrics Authors: Sedigheh Rafiei Tabatabaei Abdollah Karimi Seyed Mohsen Zahraei Abdoulreza Esteghamati Leila Azimi Fariba Shirvani Sousan Mohammadi Maryam Rajabnejad Ahmadreza Shamshiri Reyhaneh Faghihian Eiman Faghihian Source Type: research
